1. Home
  2. ZLAB vs AI Comparison

ZLAB vs AI Comparison

Compare ZLAB & AI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.67

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo C3.ai Inc.

AI

C3.ai Inc.

HOLD

Current Price

$16.09

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
AI
Founded
2013
2009
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
ZLAB
AI
Price
$18.67
$16.09
Analyst Decision
Buy
Hold
Analyst Count
6
16
Target Price
$57.22
$24.29
AVG Volume (30 Days)
810.7K
6.6M
Earning Date
11-06-2025
12-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$441,629,000.00
$352,913,000.00
Revenue This Year
$30.20
N/A
Revenue Next Year
$34.71
$11.61
P/E Ratio
N/A
N/A
Revenue Growth
24.14
1.84
52 Week Low
$18.61
$12.59
52 Week High
$44.34
$45.08

Technical Indicators

Market Signals
Indicator
ZLAB
AI
Relative Strength Index (RSI) 21.76 57.61
Support Level $19.40 $14.80
Resistance Level $20.22 $15.87
Average True Range (ATR) 0.53 0.75
MACD 0.20 0.36
Stochastic Oscillator 5.02 96.38

Price Performance

Historical Comparison
ZLAB
AI

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About AI C3.ai Inc.

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.

Share on Social Networks: